Skip to main content

Table 2 Coverage of various components of WHO recommendations by Global Network region and site among women who reported at least one antenatal care visit, 2010-2013

From: A prospective observational description of frequency and timing of antenatal care attendance and coverage of selected interventions from sites in Argentina, Guatemala, India, Kenya, Pakistan and Zambia

  Africa Asia Latin America Total
  Kenya Zambia Belgaum Nagpur Pakistan Argentina Guatemala  
Tetanus toxoid vaccine, N (%) 32,032 (92.5) 26,273 (95.8) 79,207 (99.8) 39,111 (99.7) 23,138 (57.1) 8,871 (96.0) 19,310 (67.2) 227,942 (88.0)
Prenatal vitamins/iron, N (%) 32,645 (94.3) 27,115 (98.9) 78,934 (99.6) 38,928 (99.5) 29,567 (73.0) 8,222 (89.3) 26,685 (92.5) 242,096 (93.5)
Syphilis test**, N (%) 27,650 (79.8) 23,338 (85.1) 14,753 (18.8) 18,073 (46.7) 59 (0.1) 8,799 (95.3) 12,847 (44.8) 105,460 (48.6)
HIV test**, N (%) 33,403 (96.4) 26,883 (98.0) 78,412 (99.4) 38,310 (97.9) 147 (0.4) 8,747 (94.8) 13,056 (45.6) 198,811 (91.2)
Hemoglobin taken, N (%) 11,300 (32.6) 5,658 (20.6) 68,271 (86.0) 38,620 (98.5) 694 (1.7) 4,142 (44.5) 121 (0.4) 128,806 (49.7)
Maternal height taken, N (%) 11 (0.0) 27,368 (99.8) 74,064 (93.3) 39,201 (100.0) 40,338 (99.5) 6,533 (70.2) 18,566 (64.3) 206,081 (79.5)
Maternal weight taken, N (%) 25,393 (73.3) 27,327 (99.7) 75,077 (94.6) 39,191 (99.9) 40,327 (99.5) 8,293 (89.1) 17,929 (62.1) 233,537 (90.1)
  1. *Numbers less than total reflect missing
  2. **Pakistan numbers omitted from total column because testing not part of recommended ANC package